Fred Knechtel is the Chief Financial Officer, Treasurer, Secretary at Interpace Biosciences Inc.
Fred Knechtel is 59, he's been the Chief Financial Officer, Treasurer és Secretary of Interpace Biosciences Inc since 2020. There are 4 older and 5 younger executives at Interpace Biosciences Inc. The oldest executive at Interpace Biosciences Inc is Stephen Sullivan, 73, who is the Chairman of the Board.
Fred's mailing address filed with the SEC is C/O INTERPACE BIOSCIENCES, INC., 300 INTERPACE PARKWAY, PARSIPPANY, NJ, 07054.
Over the last 9 years, insiders at Interpace Biosciences Inc have traded over $0 worth of Interpace Biosciences Inc stock and bought 94,105 units worth $353,961 . The most active insiders traders include Peter Kamin, Nat Krishnamurti és Graham G Miao. On average, Interpace Biosciences Inc executives and independent directors trade stock every 99 days with the average trade being worth of $48,561. The most recent stock trade was executed by Thomas W. Burnell on 21 May 2021, trading 10,855 units of IDXG stock currently worth $94,221.
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Interpace Biosciences Inc executives and other stock owners filed with the SEC include: